GSK-3 Phosphorylation of the Alzheimer Epitope within Collapsin Response Mediator Proteins Regulates Axon Elongation in Primary Neurons

This publication has 33 references indexed in Scilit:

• The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer’s disease-like tau phosphorylation
  Biochemical and Biophysical Research Communications, 2004
• NGF-Induced Axon Growth Is Mediated by Localized Inactivation of GSK-3β and Functions of the Microtubule Plus End Binding Protein APC
  Neuron, 2004
• Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event
  Biochemical Journal, 2004
• Role of CRMP‐2 in neuronal polarity
  Journal of Neurobiology, 2003
• Inhibition of glycogen synthase kinase 3β in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones
  Molecular and Cellular Neuroscience, 2003
• CRMP-2 binds to tubulin heterodimers to promote microtubule assembly
  Nature Cell Biology, 2002
• GSK3 takes centre stage more than 20 years after its discovery
  Biochemical Journal, 2001
• A GSK3‐binding peptide from FRAT1 selectively inhibits the GSK3‐catalysed phosphorylation of Axin and β‐catenin
  FEBS Letters, 1999
• τ is phosphorylated by GSK‐3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A‐kinase
  FEBS Letters, 1998
• Localization and Developmental Changes of τ Protein Kinase I/Glycogen Synthase Kinase‐3β in Rat Brain
  Journal of Neurochemistry, 1994